Search
Pioneering immunotherapy to find and kill elusive cancer cells in children at Lucile Packard Childre
- OPACC
- Feb 13, 2018
- 1 min read
The "remarkably successful" CAR-T cell therapy is giving new hope to the sickest cancer patients. Now, Stanford experts are focusing on advancing its use and broadening its benefits.
Recent Posts
See AllQuality of life improvements can be made if clinicians better understand auditory attention decay after cancer treatment in pediatric...
A team of experts, issuing a statement on behalf of the American Heart Association, have detailed cardiometabolic considerations for...
While the overall prevalence of comorbidities at diagnosis in pediatric patients with acute lymphoblastic leukemia (ALL) and...